Business Description
IR-Med Inc
NAICS : 325413
SIC : 5047
ISIN : US46265R1032
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.8 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -86.2 | |||||
3-Year EPS without NRI Growth Rate | -85.3 | |||||
3-Year FCF Growth Rate | -98.6 | |||||
3-Year Book Growth Rate | -39 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 98.31 | |||||
9-Day RSI | 89.83 | |||||
14-Day RSI | 76.96 | |||||
6-1 Month Momentum % | -72.31 | |||||
12-1 Month Momentum % | -70.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 2.15 | |||||
Cash Ratio | 2.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.7 | |||||
Shareholder Yield % | 0.16 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -449.64 | |||||
ROA % | -253.13 | |||||
ROIC % | -1558.3 | |||||
3-Year ROIIC % | -1786.75 | |||||
ROC (Joel Greenblatt) % | -2620.66 | |||||
ROCE % | -398.97 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 53 | |||||
Price-to-Tangible-Book | 53 | |||||
EV-to-EBIT | -10.62 | |||||
EV-to-Forward-EBIT | -45.1 | |||||
EV-to-EBITDA | -10.67 | |||||
EV-to-Forward-EBITDA | -45.22 | |||||
EV-to-Forward-Revenue | 6.71 | |||||
EV-to-FCF | -12.07 | |||||
Earnings Yield (Greenblatt) % | -9.42 | |||||
FCF Yield % | -6.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
IR-Med Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.06 | ||
Beta | 1.59 | ||
Volatility % | 95.83 | ||
14-Day RSI | 76.96 | ||
14-Day ATR ($) | 0.015027 | ||
20-Day SMA ($) | 0.403875 | ||
12-1 Month Momentum % | -70.73 | ||
52-Week Range ($) | 0.33999 - 1.65 | ||
Shares Outstanding (Mil) | 70.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IR-Med Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IR-Med Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
IR-Med Inc Frequently Asked Questions
What is IR-Med Inc(IRME)'s stock price today?
When is next earnings date of IR-Med Inc(IRME)?
Does IR-Med Inc(IRME) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |